[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0346-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0347-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0349-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-03-04 | Class I | Oregon Potato Company LLCH-0522-2026 | Listeria monocytogenes | Environmental Monitoring |
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0350-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0348-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-03-04 | Class II | Wizcure Pharmaa Private LimitedD-0352-2026 | Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. | Environmental Monitoring |
| 2026-02-25 | Class II | Lotus Mom Corporation dba Indian Kitchen MartH-0511-2026 | Potential contamination with leachable lead. | Environmental Monitoring |
| 2026-02-25 | Class I | Lotus Mom Corporation dba Indian Kitchen MartH-0514-2026 | Potential contamination with leachable lead. | Environmental Monitoring |
| 2026-02-25 | Class II | Lotus Mom Corporation dba Indian Kitchen MartH-0512-2026 | Potential contamination with leachable lead. | Environmental Monitoring |
| 2026-02-25 | Class II | Woodland Foods LLCH-0515-2026 | Possible presence of Foreign Material | Environmental Monitoring |
| 2026-02-25 | Class II | Lotus Mom Corporation dba Indian Kitchen MartH-0513-2026 | Potential contamination with leachable lead. | Environmental Monitoring |
| 2026-02-25 | Class I | Art Monkey LLC dba Why Not NaturalH-0510-2026 | Potential to be contaminated with Salmonella | Environmental Monitoring |
| 2026-02-25 | Class II | H & N Group Inc.H-0516-2026 | Product manufactured under insanitary conditions whereby it may have been contaminated with Cesium-137 (Cs-137) | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0324-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0325-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0314-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0317-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0331-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0326-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0313-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0308-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | Fresenius Kabi Compounding, LLCD-0335-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0323-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
| 2026-02-18 | Class II | F.H. INVESTMENTS, Inc. (dba Asteria Health)D-0315-2026 | Presence of Foreign substance - potential presence of metal particulate matter | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.